PRESS RELEASE

FRI, MAR 20, 2020 09:30 CET

ChloraSolv is awarded on wound care tender in Region Kalmar Country Council and its municipalities

During the fall of 2019, RLS Global has worked intensively on the Swedish market with the aim to establish ChloraSolv as a product in the Swedish regions. In parallel, RLS has worked in close collaboration with OneMed to penetrate the market (municipalities and regions) where OneMed has agreements. As RLS has communicated in the past, the work carried out during the autumn of 2019 will generate positive results during Q1 and Q2 2020.

RLS can now inform that ChloraSolv has been awarded on the wound care tender agreement in the Kalmar County Council and its municipalities. The contract is valid as of 20th of March 2020. The outcome of the clinical evaluation has been very positive and ChloraSolv can now be offered to healthcare providers in the region.

“The law on public procurement requires that the regions clinically evaluate new technologies. It is a positive recognition that we now are now approved in our first country council. RLS has now full access to establish ChloraSolv in this region, says Karin Fischer, CEO of RLS Global. We are convinced that we will achieve more agreements of this nature in the near future, continues Karin.”

Trading place and certified advisor

RLS Global’s shares has been listed on the Nasdaq First North since 17th May, 2017 and trading takes place under the short name RLS. Certified Adviser is Erik Penser Bank, telephone +46 8 463 83 00, Email: certifiedadviser@penser.se. During the period 2012 – 2017, the company was listed on Aktietorget.

 

For more information, please contact:
Karin Fischer, CEO RLS Global AB,
+46 (0)702 48 46 51, karin.fischer@rlsglobal.se

Anders Husmark, CBDO RLS Global AB,
+46 (0)72 450 94 03, anders.husmark@rlsglobal.se

RLS Global AB is a medical technology company within Life Science. Based on the company’s unique hypochlorite platform, RLS  Global develop products for some of our most common illnesses in wound and oral care. RLS Global has a portfolio of strong brands, including ChloraSolv® and Carisolv®. The company is listed on Nasdaq First North with Erik Penser Bank as Certified Adviser, telephone +46 (0) 8 463 83 00, email: certified adviser@penser.se. Read more at www.rls.global

Press Release